Abstract: A lint mitt having a compartment for a user's fingers, a compartment for a user's thumb, and which firmly holds the mitt about a user's wrist. The lint mitt has disposed thereon an adhesive having sufficient tack to adhere lint to the lint mitt when the lint mitt is disposed upon a lint-filled surface. Methods for using a lint mitt.

Abstract: The present invention relates to non-spherical and/or non-platelet pyrithione particles. Also disclosed is a method for producing non-spherical and/or non-platelet particles of pyrithione salts, comprising reacting pyrithione or a water-soluble salt of pyrithione and a water-soluble polyvalent metal salt in the presence of a dispersant at a temperature from about 20.degree. C. to about 60.degree. C. to produce non-spherical and/or non-platelet particles of pyrithione salts. The present invention further relates to particles made by the above methods and products, such as shampoos, soaps, and skin-care medicaments made using these particles.

Abstract: A new oral pharmaceutical dosage form comprising a core material that contains a proton pump inhibitor, one or more alkaline reacting compounds and optionally pharmaceutical excipients having a water soluble separating layer and an enteric coating layer. The core material as such is alkaline reacting and the separating layer between the alkaline reacting core material and the enteric coating layer is formed in situ as a water soluble salt between the alkaline reacting compound(s) and the enteric coating polymer. The invention also describes a new efficient process for the manufacture of such a dosage form comprising two functionally different layers in one manufacturing step, and its use in medicine.

Abstract: A mild wave and hair styling reducing agent-containing composition and method of bodifying, styling, or permanently waving or straightening human hair that provides a strong, long lasting curl, or long lasting straight hair formation, while minimizing hair damage. The composition includes two ionic compounds, one cationic and the other anionic, that complex in solution over a molar ratio of cationic compound to anionic compound in the range of about 1:1.2 to about 1.2:1, preferably in the range of about 1:1.1 to about 1.1:1, to provide synergy in waving efficiency, thereby providing a strongly reconfigured hair configuration (curled or straightened). At least one of the ionic compounds functions as a reducing agent for hair, capable of breaking the disulfide bonds in the hair so that the bonds later can be reformed via oxidation, when the hair is in the desired configuration.

Abstract: The invention deals with microspheres which are useful in pharmaceutical dosage forms. The microspheres contain active agents and solubilizing agents which have been processed via liquiflash techniques.

Abstract: The present invention relates to dust free, easily flowable and dosable granular compositions containing triazine, having a particle size distribution of between 40 and 400.mu. and an upper limit of particle size at 2000.mu., which can be effectively mixed with feed for administration to animals.

Abstract: Disclosed are aqueous conditioning shampoo compositions containing a surfactant component in a shampoo with a particulate insoluble, dispersed, non-volatile conditioning agent having a particle size range of less than about 0.15 microns, crystalline agent and a deposition polymer.

Abstract: A method of treatment of osteo-articular disease which includes administering an effective amount of a pharmaceutical composition containing a compound of specified formula and an excipient to a patient in need of such treatment. The compounds of specified formula have a phosphonate group on one end and a silanol or silanol precursor on the opposite end, and can inhibit serine proteases.

Abstract: A process for producing solid combination tablets which have at least two phases comprises molding a melt of a polymeric binder with or without at least one active ingredient, there being at least one solid product, which may contain an active ingredient incorporated into the still plastic composition during the molding step.

Abstract: A sodium phosphate bowel cleansing composition which has improved taste over conventional sodium phosphate compositions. The composition comprising free flowing monobasic sodium phosphate and dibasic sodium phosphate powders or crystals which have been coated with at least one edible grade film forming polymer such as hydroxypropylmethyl cellulose or polyethylene glycol.

Abstract: An aqueous solution of droperidol suitable for injection having a concentration from about 0.1 to about 10.0 mg/ml, and a sufficient amount of tonicity adjusting agent to render the solution isotonic, the solution being in a sealed container. Also provided is an aqueous solution of droperidol suitable for injection, comprising droperidol at a concentration from about 2.75 to about 10 mg/ml, and the solution being in a sealed container.

Abstract: Compositions for a hand and body creme made substantially of naturally occurring ingredients are described. Such compositions are highly effective in clearing eczema and other common skin ailments. One embodiment, in which the hand and body creme is a creamy solid, is made by forming an admixture of cocoa butter, almond oil, jojoba oil, vitamin E oil, a commercially available beeswax derivative, hydrogenated soybean flakes, pure beeswax and vitamin A oil. In alternate embodiments, water, shea butter and honey are added to vary the consistency and moisturizing properties of the composition. In still other embodiments, essential oils from a variety of plant sources are added for a range of fragrances.

Abstract: A hair conditioner composition comprising, by weight of the total composition:0.1-20% of a cationic conditioning agent,0.1-20% of esters of alpha or beta hydroxy acids,0.1-30% of a fatty alcohol,0.001-10% of a nonionic surfactant, and5-95% water.

Abstract: Cross-linked cellulose is an excellent binder disintegrant that can be used in the preparation of pharmaceutical tablets. The tablets that are so prepared are made of a compressed mixture of a powder of a pharmaceutically active ingredient with a powder of a pharmaceutical excipient including a pharmaceutically acceptable form of cross-linked cellulose in an amount up to 35% by weight with respect to the total weight of the tablet. The cross-linked cellulose is prepared by cross-linking microcrystalline or fibrous cellulose with a cross-linking agent such as epichlorhydrin in a relative amount of 2 to 50 g of cross-linking agent per 100 g of cellulose. Tests have proved that cross-linked cellulose is very easy to synthetise and has excellent binding/disintegrating properties that are function of the cross-linking degree. At low cross-linking degree, cross-linked cellulose is more a binder than a disintegrant whereas at high cross-linking degree, it is more a disintegrant than a binder.

Abstract: A device which produces adequate local anesthesia for the purpose of infant male circumcision. The elastic form fitting body of the device is measured to fit over the infant male penis, and contains a coated inner surface that contacts the penile skin with an anesthetic gel, which upon contact, initiates anesthesia locally at the glans tip of the infant penis.

Abstract: A cosmetic composition for the first step of an operation for the permanent deformation of hair, the composition containing an N-mercaptoalkylalkanediamide or one of its cosmetically acceptable salts as a reducing agent, including new N-mercaptoalkylalkanediamide disulphides and new N-mercaptoalkylalkanediamides, and its use in a process for the permanent deformation of hair.

Abstract: An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation.

Abstract: Disclosed are aqueous conditioning shampoo compositions containing a surfactant component in a shampoo with a particulate insoluble, dispersed, non-volatile conditioning agent having a dual particle size range, suspending agent and a deposition polymer.

Abstract: A new pharmaceutical composition is disclosed that comprises clioquinol, vitamin B.sub.12, and, optionally, pharmaceutical acceptable carriers and/or excipients. The use of the pharmaceutical composition removes or alleviates the side effects of clioquinol.

Abstract: Conductive, flowable, emollient compositions and electrostatic methods for their application e.g., to tissue, are disclosed. Compositions of the invention include emollient(s) and conductivity modifiers. Emollient-compatible phosphates and succinates are particularly preferred families of conductivity modifiers. In methods of the invention conductive emollient composition of the invention are preferably applied to tissue substrates, particularly facial tissue substrates, and particularly in a commercial tissue-making process. Electrostatic spray processes are utilized to obtain surprisingly uniform application of conductive emollient to tissue with minimal overspray or spray path overlap.